STOCK TITAN
  1. Home
  2. News
  3. BDPTD
  4. BioAdaptives® PawPa™ Regen Provides Breakthrough Stem Cell Support for Pets, Backed by Clinically Proven APBAR® Scale Improvements

BioAdaptives® PawPa™ Regen Provides Breakthrough Stem Cell Support for Pets, Backed by Clinically Proven APBAR® Scale Improvements

Rhea-AI Impact
(Moderate)
Rhea-AI Sentiment
(Positive)
Tags
Rhea-AI Summary
BioAdaptives' pets division PawPa™ has announced breakthrough results for its Regen Dog Chews, a product designed to enhance stem cell production in dogs. Clinical trials demonstrated remarkable increases in circulating stem cells: 96.2% after two weeks and 281.3% after four weeks. The company introduced the APBAR® rating system (Appearance, Performance, Behavior, Attitude, and Responsiveness) to measure improvements in pet health. The product, formulated with natural cyanobacteria and adaptogens, showed significant benefits in coat health, mobility, energy levels, and cognitive function. Veterinarian trials reported no adverse effects, confirming the product's safety profile. The chews are now available through PawPa.com, offering pet owners a measurable way to support their dogs' wellness through cellular rejuvenation.
La divisione per animali domestici di BioAdaptives, PawPa™, ha annunciato risultati rivoluzionari per i suoi Regen Dog Chews, un prodotto studiato per aumentare la produzione di cellule staminali nei cani. I trial clinici hanno mostrato aumenti straordinari delle cellule staminali circolanti: 96,2% dopo due settimane e 281,3% dopo quattro settimane. L'azienda ha introdotto il sistema di valutazione APBAR® (Aspetto, Prestazioni, Comportamento, Atteggiamento e Reattività) per misurare i miglioramenti nella salute degli animali. Il prodotto, formulato con cianobatteri naturali e adattogeni, ha evidenziato benefici significativi nella salute del pelo, nella mobilità, nei livelli di energia e nelle funzioni cognitive. I test veterinari non hanno riportato effetti collaterali, confermando il profilo di sicurezza del prodotto. Le masticabili sono ora disponibili su PawPa.com, offrendo ai proprietari un modo misurabile per supportare il benessere dei loro cani attraverso il ringiovanimento cellulare.
La división de mascotas de BioAdaptives, PawPa™, ha anunciado resultados innovadores para sus Regen Dog Chews, un producto diseñado para aumentar la producción de células madre en perros. Los ensayos clínicos demostraron incrementos notables en las células madre circulantes: 96.2% después de dos semanas y 281.3% después de cuatro semanas. La compañía introdujo el sistema de calificación APBAR® (Apariencia, Rendimiento, Comportamiento, Actitud y Receptividad) para medir las mejoras en la salud de las mascotas. El producto, formulado con cianobacterias naturales y adaptógenos, mostró beneficios significativos en la salud del pelaje, la movilidad, los niveles de energía y la función cognitiva. Los ensayos veterinarios no reportaron efectos adversos, confirmando el perfil de seguridad del producto. Las masticables ya están disponibles en PawPa.com, ofreciendo a los dueños una forma medible de apoyar el bienestar de sus perros mediante la rejuvenecimiento celular.
BioAdaptives의 반려동물 부문인 PawPa™는 강아지의 줄기세포 생성을 촉진하기 위해 개발된 Regen Dog Chews의 획기적인 결과를 발표했습니다. 임상 시험에서 순환하는 줄기세포가 2주 후 96.2%, 4주 후 281.3% 증가하는 놀라운 수치를 보였습니다. 회사는 반려동물 건강 개선을 측정하기 위해 APBAR® 평가 시스템(외관, 수행능력, 행동, 태도, 반응성)을 도입했습니다. 천연 남조류와 아답토젠으로 제조된 이 제품은 털 건강, 이동성, 에너지 수준, 인지 기능에서 유의미한 효과를 나타냈습니다. 수의사 시험에서 부작용이 보고되지 않아 제품의 안전성이 확인되었습니다. 이 츄어블은 현재 PawPa.com에서 구매 가능하며, 반려견의 세포 재생을 통한 건강 증진을 측정 가능한 방식으로 지원합니다.
La division animaux de compagnie de BioAdaptives, PawPa™, a annoncé des résultats révolutionnaires pour ses Regen Dog Chews, un produit conçu pour stimuler la production de cellules souches chez les chiens. Les essais cliniques ont montré des augmentations remarquables des cellules souches circulantes : 96,2 % après deux semaines et 281,3 % après quatre semaines. L'entreprise a introduit le système de notation APBAR® (Apparence, Performance, Comportement, Attitude et Réactivité) pour mesurer les améliorations de la santé des animaux. Formulé avec des cyanobactéries naturelles et des adaptogènes, le produit a démontré des bienfaits significatifs sur la santé du pelage, la mobilité, les niveaux d'énergie et les fonctions cognitives. Les essais vétérinaires n'ont rapporté aucun effet indésirable, confirmant le profil de sécurité du produit. Les chewing-gums sont désormais disponibles sur PawPa.com, offrant aux propriétaires une méthode mesurable pour soutenir le bien-être de leurs chiens grâce au rajeunissement cellulaire.
Die Haustierabteilung von BioAdaptives, PawPa™, hat bahnbrechende Ergebnisse für seine Regen Dog Chews bekanntgegeben, ein Produkt zur Steigerung der Stammzellproduktion bei Hunden. Klinische Studien zeigten bemerkenswerte Zunahmen der zirkulierenden Stammzellen: 96,2 % nach zwei Wochen und 281,3 % nach vier Wochen. Das Unternehmen führte das APBAR®-Bewertungssystem (Aussehen, Leistung, Verhalten, Einstellung und Reaktionsfähigkeit) ein, um Verbesserungen der Tiergesundheit zu messen. Das Produkt, formuliert mit natürlichen Cyanobakterien und Adaptogenen, zeigte signifikante Vorteile für Fellgesundheit, Mobilität, Energielevel und kognitive Funktionen. Veterinärstudien berichteten keine Nebenwirkungen, was das Sicherheitsprofil des Produkts bestätigt. Die Kausnacks sind jetzt über PawPa.com erhältlich und bieten Tierhaltern eine messbare Möglichkeit, das Wohlbefinden ihrer Hunde durch zelluläre Verjüngung zu unterstützen.
Positive
  • Clinical trials showed significant stem cell increases of 96.2% (2 weeks) and 281.3% (4 weeks)
  • No adverse effects reported in veterinarian trials
  • Development of proprietary APBAR® rating system for measuring pet health improvements
  • Product demonstrated multiple benefits including improved mobility, coat health, and cognitive function
Negative
  • None.

Regen Dog Chews are crafted to the highest quality standards, recommended by veterinarians and proven safe with no adverse effects reported in clinical trials

LAS VEGAS, May 28, 2025 (GLOBE NEWSWIRE) -- via IBN -- BioAdaptives, Inc. (OTC: BDPT), through its pets division PawPa™, a leader in premium pet wellness, proudly announces the remarkable stem cell benefits of its flagship product, Regen Dog Chews, validated through rigorous clinical testing and the innovative APBAR® rating system. Designed to restore vitality, enhance comfort, and improve mobility in aging or injured dogs, Regen is revolutionizing pet care by harnessing the power of cellular rejuvenation through stem cells.

Regen Dog Chews are formulated with advanced nutraceuticals and all-natural ingredients, clinically proven to stimulate the release of circulating stem cells - key players in tissue repair and regeneration. In a groundbreaking veterinarian trial, Regen demonstrated a 96.2% increase in circulating stem cells after two weeks, soaring to a 281.3% increase after four weeks. A subsequent canine study mirrored these results, with veterinarians observing significant improvements in dogs’ overall wellness, including shinier coats, enhanced stamina, faster recovery, and improved responsiveness to commands.

To quantify these transformative effects, PawPa™ BioAdaptives® developed the APBAR® rating system (Appearance, Performance, Behavior, Attitude and Responsiveness) a comprehensive tool inspired by the human APGAR score for newborns. The APBAR® scale empowers pet owners to track their dog’s health improvements with measurable criteria:

  • Appearance: Regen’s natural ingredients nourish the skin and coat, promoting a healthy shine and vibrant posture. Dogs showed noticeable improvements in coat luster within weeks.
  • Performance: Regen showed mobility enhancing properties, with aging dogs regaining their ability to run, jump, and play. Owners reported increased endurance and stamina.
  • Behavior: Increased circulating stem cells boosted cellular rejuvenation, leading to more playful and energetic dogs with balanced sleep patterns.
  • Attitude: Dogs displayed happier, more attentive expressions and balanced moods, reflecting Regen’s anti-aging benefits.
  • Responsiveness: Improved focus, obedience, and memory were observed, keeping dogs sharp and engaged.

“Pet owners want results they can see and trust, not just promises,” said James Keener, CEO at BioAdaptives®. “Regen Dog Chews deliver on that commitment. By targeting cellular rejuvenation, we’re helping dogs thrive at every stage of life, and the APBAR® system lets owners measure that progress firsthand. From a shinier coat to joyful leaps, every improvement is a testament to their pet’s vitality.”

Crafted with the highest quality standards, from all-natural ingredients of beneficial cyanobacteria and adaptogens, Regen Dog Chews are veterinarian-recommended and safe, with no adverse effects reported in clinical trials. The tasty treat delivery system ensures dogs love every bite, making it easy for owners to support their pet’s wellness daily.

PawPa™ invites pet owners to experience the difference Regen can make. Start by rating your dog on the APBAR® scale and track their progress with Regen Dog Chews. Available now at PawPa.com. Every wag of the tail, every nuzzle, is a moment for celebration.

Contact:

BioAdaptives, Inc.
Emily Harrison
IR Coordinator
(702)-659-8829
info@bioadaptives.com
2620 Regatta Dr, Suite 102
Las Vegas, NV 89128

Forward-Looking Statements: This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements include, among other things, statements regarding expected growth, potential benefits of the company's products, and future business opportunities. These statements involve risks, uncertainties, and other factors that may cause actual results or developments to differ materially from those expressed or implied.

Wire Service Contact:

IBN
Austin, Texas
www.InvestorBrandNetwork.com
512.354.7000 Office
Editor@InvestorBrandNetwork.com


FAQ

What are the clinical trial results for BioAdaptives (BDPTD) Regen Dog Chews?

Clinical trials showed a 96.2% increase in circulating stem cells after two weeks and a 281.3% increase after four weeks, with improvements in coat health, mobility, and cognitive function.

What is the APBAR® rating system developed by PawPa BioAdaptives?

APBAR® is a comprehensive rating system that measures pet health improvements across five criteria: Appearance, Performance, Behavior, Attitude, and Responsiveness, inspired by the human APGAR score.

Are BioAdaptives (BDPTD) Regen Dog Chews safe for pets?

Yes, the product is veterinarian-recommended and showed no adverse effects in clinical trials. It's made from all-natural ingredients including cyanobacteria and adaptogens.

Where can I purchase PawPa Regen Dog Chews?

Regen Dog Chews are available for purchase through the company's website at PawPa.com.
Stock BDPTD logo
Bioadaptives

OTC:BDPTD

BDPTD Rankings

N/A Ranked by Market Cap
N/A Ranked by Dividends

BDPTD Latest News

Mar 13, 2025
Zeranovia(TM) Weight Loss Product Shows Promising Results in Dosage Trial
Feb 6, 2025
BioAdaptives Welcomes UFC Senior Executive Reed Harris to Its Board of Advisors
Feb 3, 2025
BioAdaptives Welcomes Mark Frissora, Acclaimed Business Leader, to Its Board of Directors
Jan 21, 2025
BioAdaptives Announces FINRA Approval of a Dividend for Common Stock Shareholders
Dec 10, 2024
BioAdaptives, Inc. Launches Xcellara™ Stem Cell Activator – Harnessing Nature for Optimal Health

BDPTD Stock Data

410.17k
4.10M
0.18%
Packaged Foods
Consumer Defensive
Link
United States
Las Vegas